{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:07:20Z","timestamp":1760242040579,"version":"build-2065373602"},"reference-count":93,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:00:00Z","timestamp":1543881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Parkinson\u2019s disease (PD) and atypical parkinsonian syndromes are age-dependent multifactorial neurodegenerative diseases, which are clinically characterized by bradykinesia, tremor, muscle rigidity and postural instability. Although these diseases share several common clinical phenotypes, their pathophysiological aspects vary among the disease categories. Extensive animal-based approaches, as well as postmortem studies, have provided important insights into the disease mechanisms and potential therapeutic targets. However, the exact pathological mechanisms triggering such diseases still remain elusive. Furthermore, the effects of drugs observed in animal models are not always reproduced in human clinical trials. By using induced pluripotent stem cell (iPSC) technology, it has become possible to establish patient-specific iPSCs from their somatic cells and to effectively differentiate these iPSCs into different types of neurons, reproducing some key aspects of the disease phenotypes in vitro. In this review, we summarize recent findings from iPSC-based modeling of PD and several atypical parkinsonian syndromes including multiple system atrophy, frontotemporal dementia and parkinsonism linked to chromosome 17 and Perry syndrome. Furthermore, we discuss future challenges and prospects for modeling and understanding PD and atypical parkinsonian syndromes.<\/jats:p>","DOI":"10.3390\/ijms19123870","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T11:56:18Z","timestamp":1543924578000},"page":"3870","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Modeling Parkinson\u2019s Disease and Atypical Parkinsonian Syndromes Using Induced Pluripotent Stem Cells"],"prefix":"10.3390","volume":"19","author":[{"given":"Takayasu","family":"Mishima","sequence":"first","affiliation":[{"name":"Department of Neurology, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Fujioka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Fukae","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Yuasa-Kawada","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Tsuboi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci","volume":"10","author":"Chang","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","article-title":"Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies","volume":"67","author":"Uryu","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","article-title":"Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases","volume":"114","author":"Uryu","year":"2007","journal-title":"Acta Neuropathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-010-0702-1","article-title":"Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy","volume":"120","author":"Yokota","year":"2010","journal-title":"Acta Neuropathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00401-013-1087-8","article-title":"Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: An unusual clinicopathologic variant of CBD","volume":"125","author":"Kouri","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2990.2010.01136.x","article-title":"TDP-43 pathology occurs infrequently in multiple system atrophy","volume":"37","author":"Geser","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/mds.26809","article-title":"Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy","volume":"32","author":"Koga","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/jnen\/nlx049","article-title":"Perry syndrome: A distinctive type of TDP-43 proteinopathy","volume":"76","author":"Mishima","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-1-30","article-title":"Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)","volume":"1","author":"Wszolek","year":"2006","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.parkreldis.2014.06.004","article-title":"Parkinsonian syndrome in familial frontotemporal dementia","volume":"20","author":"Siuda","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S1353-8020(13)70017-8","article-title":"\u03b1-Synucleinopathy phenotypes. Parkinsonism","volume":"20","author":"McCann","year":"2014","journal-title":"Relat. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","article-title":"Neuropathology of Parkinson disease","volume":"46","author":"Dickson","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/clpt.2011.38","article-title":"The use of induced pluripotent stem cells in drug development","volume":"89","author":"Inoue","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2016.245","article-title":"Induced pluripotent stem cell technology: A decade of progress","volume":"16","author":"Shi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nn.2577","article-title":"What can pluripotent stem cells teach us about neurodegenerative diseases?","volume":"13","author":"Wichterle","year":"2010","journal-title":"Nat. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nrg1268","article-title":"Using human neural stem cells to model neurological disease","volume":"5","author":"Jakel","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","article-title":"Genetic animal models of Parkinson\u2019s disease","volume":"66","author":"Dawson","year":"2010","journal-title":"Neuron"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-017-1788-5","article-title":"Parkinson\u2019s disease: Experimental models and reality","volume":"135","author":"Jiang","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4252\/wjsc.v7.i1.116","article-title":"Methods of induced pluripotent stem cells for clinical application","volume":"7","author":"Seki","year":"2015","journal-title":"World J. Stem Cells"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","article-title":"Induced pluripotent stem cells from a spinal muscular atrophy patient","volume":"457","author":"Ebert","year":"2009","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.cell.2009.02.013","article-title":"Parkinson\u2019s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors","volume":"136","author":"Soldner","year":"2009","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.parkreldis.2015.10.011","article-title":"Gastric motor dysfunctions in Parkinson\u2019s disease: Current pre-clinical evidence","volume":"21","author":"Pellegrini","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","article-title":"Parkinson\u2019s disease: Second of two parts","volume":"339","author":"Lange","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_31","first-page":"353","article-title":"The prevalence of constipation and irritable bowel syndrome in Parkinson\u2019s disease patients according to Rome III diagnostic criteria","volume":"7","author":"Mishima","year":"2017","journal-title":"J. Park. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/hmg\/ddp012","article-title":"Parkinson\u2019s disease: From monogenic forms to genetic susceptibility factors","volume":"18","author":"Lesage","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.stem.2011.01.013","article-title":"LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress","volume":"8","author":"Nguyen","year":"2011","journal-title":"Cell Stem Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/emmm.201200215","article-title":"Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson\u2019s disease","volume":"4","author":"Caig","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"141ra90","DOI":"10.1126\/scitranslmed.3003985","article-title":"Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson\u2019s disease","volume":"4","author":"Cooper","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1093\/hmg\/ddv212","article-title":"I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT\/GSK-3\u03b2 signaling pathway","volume":"24","author":"Ohta","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.stem.2013.01.008","article-title":"Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression","volume":"12","author":"Reinhardt","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ncomms1453","article-title":"Parkinson\u2019s disease induced pluripotent stem cells with triplication of the \u03b1-synuclein locus","volume":"2","author":"Devine","year":"2011","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"E3679","DOI":"10.1073\/pnas.1617259114","article-title":"Defective synaptic connectivity and axonal neurophathology in a human iPSC-based model familial Parkinson\u2019s disease","volume":"114","author":"Kouroupi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1523\/JNEUROSCI.4441-10.2011","article-title":"Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells","volume":"31","author":"Seibler","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ncomms1669","article-title":"Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells","volume":"3","author":"Jiang","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1756-6606-5-35","article-title":"Mitochondrial dysfunction associated with increased oxidative stress and \u03b1-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue","volume":"5","author":"Imaizumi","year":"2012","journal-title":"Mol. Brain"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbrc.2016.12.188","article-title":"Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons","volume":"483","author":"Suzuki","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.stemcr.2018.09.006","article-title":"T-type calcium channels determine the vulnerability of dopaminergic neurons to mitochondrial stress in familial Parkinson disease","volume":"11","author":"Tabata","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/nan.12396","article-title":"Distinctive genomic signature of neural and intestinal organoids from familial Parkinson\u2019s disease patient-derived induced pluripotent stem cells","volume":"43","author":"Son","year":"2017","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.stemcr.2015.07.002","article-title":"\u03b1-synuclein expression in the oligodendrocyte lineage: An in vitro and in vivo study using rodent and human models","volume":"5","author":"Djelloul","year":"2015","journal-title":"Stem Cell Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"16009","DOI":"10.1038\/npjparkd.2016.9","article-title":"Creation of a library of induced pluripotent stem cells from Parkinsonian patients","volume":"2","author":"Holmqvist","year":"2016","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.stemcr.2018.09.007","article-title":"Mitochondrial dysregulation and impaired autophagy in iPSC-derived dopaminergic neurons of multiple system atrophy","volume":"11","author":"Kleiner","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13024-015-0042-7","article-title":"Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells","volume":"10","author":"Wren","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.stemcr.2015.06.001","article-title":"Distinct neurodegenerative changes in an induced pluripotent stem cell model of frontotemporal dementia linked to mutant TAU protein","volume":"5","author":"Ehrlich","year":"2015","journal-title":"Stem Cell Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1093\/brain\/awv222","article-title":"Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations","volume":"138","author":"Iovino","year":"2015","journal-title":"Brain"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"34904","DOI":"10.1038\/srep34904","article-title":"Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons","volume":"6","author":"Imamura","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"42991","DOI":"10.1038\/srep42991","article-title":"Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein","volume":"7","author":"Hallmann","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.stemcr.2018.06.022","article-title":"Genetically engineered iPSC-derived FTDP-17 MAPT neurons display mutation-specific neurodegenerative and neurodevelopmental phenotypes","volume":"11","author":"Verheyen","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"E2849","DOI":"10.1073\/pnas.1722344115","article-title":"Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay","volume":"115","author":"Nguyen","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.celrep.2012.09.007","article-title":"Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects","volume":"2","author":"Almeida","year":"2012","journal-title":"Cell Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.stemcr.2014.12.001","article-title":"Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia","volume":"4","author":"Raitano","year":"2015","journal-title":"Stem Cell Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/jnnp-2017-316864","article-title":"Establishing diagnostic criteria for Perry syndrome","volume":"89","author":"Mishima","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/ng.293","article-title":"DCTN1 mutations in Perry syndrome","volume":"41","author":"Farrer","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neulet.2017.12.038","article-title":"Behavioral defects in a DCTN1G71A transgenic mouse model of Perry syndrome","volume":"666","author":"Mishima","year":"2018","journal-title":"Neurosci. Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.parkreldis.2016.06.007","article-title":"Cytoplasmic aggregates of dynactin in iPSC-derived tyrosine hydroxylase-positive neurons from a patient with Perry syndrome","volume":"30","author":"Mishima","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ebiom.2017.06.002","article-title":"Reduced TDP-43 expression improves neuronal activities in a drosophila model of Perry syndrome","volume":"21","author":"Hosaka","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.neuron.2013.12.018","article-title":"Axonal transport of TDP-43 mRNA granules in neurons is impaired by ALS-causing mutations","volume":"81","author":"Alami","year":"2014","journal-title":"Neuron"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nbt.3049","article-title":"Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes","volume":"33","author":"Maury","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nmeth.3507","article-title":"Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells","volume":"12","author":"Paull","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/362414a0","article-title":"Better cells for brain repair","volume":"362","year":"1993","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nrneurol.2015.123","article-title":"Cell\u2013based therapies for Parkinson disease\u2014Past insights and future potential","volume":"11","author":"Barker","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1474-4422(12)70295-8","article-title":"Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson\u2019s disease","volume":"12","author":"Barker","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/stem.1060","article-title":"Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson\u2019s disease","volume":"30","author":"Doi","year":"2012","journal-title":"Stem Cells"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1634\/stemcells.2005-0393","article-title":"Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson\u2019s disease: Effect of in vitro differentiation on graft survival and teratoma formation","volume":"24","author":"Brederlau","year":"2006","journal-title":"Stem Cells"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.stemcr.2014.01.013","article-title":"Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation","volume":"2","author":"Doi","year":"2014","journal-title":"Stem Cell Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"13097","DOI":"10.1038\/ncomms13097","article-title":"Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1","volume":"7","author":"Samata","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"E1946","DOI":"10.1073\/pnas.1501989112","article-title":"Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors","volume":"112","author":"Bye","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nature23664","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model","volume":"548","author":"Kikuchi","year":"2017","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.clpt.6100386","article-title":"Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy","volume":"83","author":"Lee","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.celrep.2013.10.018","article-title":"The presenilin-1 \u0394E9 mutation results in reduced \u03b3-secretase activity, but not total loss of PS1 function, in isogenic human stem cells","volume":"5","author":"Woodruff","year":"2013","journal-title":"Cell Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/495050a","article-title":"Biotechnology: Rewriting a genome","volume":"495","author":"Charpentier","year":"2013","journal-title":"Nature."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature10424","article-title":"Targeted gene correction of \u03b11-antitrypsin deficiency in induced pluripotent stem cells","volume":"478","author":"Yusa","year":"2011","journal-title":"Nature"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nature17664","article-title":"Efficient introduction of specific homozygous and heterozygous mutations using CRISPR\/Cas9","volume":"533","author":"Paquet","year":"2016","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.stemcr.2016.07.001","article-title":"A Cas9 Variant for Efficient Generation of Indel-Free Knockin or Gene-Corrected Human Pluripotent Stem Cells","volume":"7","author":"Howden","year":"2016","journal-title":"Stem Cell Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbt.2017.05.009","article-title":"Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges","volume":"39","author":"Poon","year":"2017","journal-title":"New Biotechnol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature25032","article-title":"The rise of three-dimensional human brain cultures","volume":"553","year":"2018","journal-title":"Nature"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.3415","article-title":"Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture","volume":"12","author":"Sloan","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.stem.2016.07.005","article-title":"Midbrain-like Organoids from Human pluripotent stem cells contain functional dopaminergic and neuromelanin-producing neurons","volume":"19","author":"Jo","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm.3983","article-title":"Parkinson\u2019s disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes","volume":"22","author":"Wang","year":"2016","journal-title":"Nat. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.stem.2015.05.004","article-title":"Programming and reprogramming cellular age in the era of induced pluripotency","volume":"16","author":"Studer","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","article-title":"Human iPSC-based modeling of late-onset disease via progerin-induced aging","volume":"13","author":"Miller","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Compagnucci, C., and Bertini, E. (2017). The potential of iPSCs for the treatment of premature aging disorders. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18112350"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/12\/3870\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:31:05Z","timestamp":1760196665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/12\/3870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,4]]},"references-count":93,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["ijms19123870"],"URL":"https:\/\/doi.org\/10.3390\/ijms19123870","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2018,12,4]]}}}